MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jep.2026.121846

Медицинская библиотека · Journal of ethnopharmacology · 2026

Mechanism of Jianpi Qinghua granule in ameliorating metabolic dysfunction-associated fatty liver disease by targeting the DNMT-urea cycle axis.

Xiao Yanyan, Wu Huayi, Ju WenXiong, Xu Junfei, Chen Chi, Abuduhelili Bilikezi, Cai Mengjie, Jin Shenyi, Yin Qinyi, Tian Jing, Lu Hao, Han Xu

СтатьяПеревод в очереди

Аннотация

ETHNOPHARMACOLOGICAL RELEVANCE: Jianpi Qinghua Granule (JPQH) is a hospital-prepared traditional Chinese medicine formula used for insulin resistance and related metabolic disorders. However, its pharmacodynamic basis and epigenetic mechanisms in metabolic dysfunction-associated fatty liver disease (MAFLD) remain unclear.

AIM OF THE STUDY: This study aimed to evaluate the therapeutic effects of JPQH on high-fat diet (HFD)-induced MAFLD and determine whether its action involves regulation of DNMT-mediated DNA methylation and hepatic urea cycle metabolism.

MATERIALS AND

METHODS

HFD-induced MAFLD mice were treated with JPQH for 4 weeks. Blood-absorbed constituents were identified by UHPLC-Q Exactive Orbitrap MS/MS. Network pharmacology, liver transcriptomics, and targeted metabolomics were integrated to explore mechanisms. Pyrosequencing, RT-qPCR, Western blotting, molecular docking, and molecular dynamics simulations were used for validation.

RESULTS

JPQH ameliorated glucose-lipid metabolic disorders and liver injury, as indicated by reduced serum TC, TG, ALT, and AST levels (P < 0.05), decreased hepatic MDA levels (P < 0.01), improved OGTT/ITT responses (P < 0.001), restored GSH/GSSG ratio (P < 0.05), and downregulation of inflammatory- and fibrosis-related gene expression (P < 0.05). A total of 44 blood-absorbed constituents and 87 JPQH-MAFLD overlapping targets were identified. Integrated analyses highlighted nitrogen metabolism and arginine and proline metabolism. JPQH restored urea cycle intermediates, upregulated CPS1, OTC, ASS1, ASL, and ARG1 expression (P < 0.01), and reduced hepatic ammonia accumulation (P < 0.01). Mechanistically, JPQH reduced DNMT1/DNMT3A expression, attenuated promoter hypermethylation of urea cycle enzyme genes, and restored their transcriptional and protein expression. Core flavonoids, including genistein, baicalein, nepetin, hispidulin, and quercetin 3,4'-dimethylether, exhibited stable binding to DNMT1 and DNMT3A in silico.

CONCLUSIONS

JPQH exerts protective effects against MAFLD by restoring hepatic nitrogen metabolism and ammonia detoxification via epigenetic regulation of the DNMT-urea cycle axis.

Для цитирования: Xiao Yanyan, Wu Huayi, Ju WenXiong, Xu Junfei, Chen Chi, Abuduhelili Bilikezi, Cai Mengjie, Jin Shenyi, Yin Qinyi, Tian Jing, Lu Hao, Han Xu. Mechanism of Jianpi Qinghua granule in ameliorating metabolic dysfunction-associated fatty liver disease by targeting the DNMT-urea cycle axis.. Journal of ethnopharmacology. 2026. DOI: 10.1016/j.jep.2026.121846.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.